NSPR · NASDAQ
InspireMD (NSPR) Stock Price & Fundamentals
InspireMD (NSPR) closed at $514.09 on Oct 9, 2026, up 1.09% from the previous close of $508.57.
Share price, past year
1Y +10.11%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $514.09 |
| Sep 30, 2026 | $521.78 |
| Aug 31, 2026 | $517.59 |
| Jul 31, 2026 | $529.35 |
| Jun 30, 2026 | $499.57 |
| May 29, 2026 | $509.14 |
| Apr 30, 2026 | $518.25 |
| Mar 31, 2026 | $472.14 |
| Feb 27, 2026 | $479.97 |
| Jan 30, 2026 | $476.63 |
| Dec 31, 2025 | $481.29 |
| Nov 28, 2025 | $478.15 |
| Oct 31, 2025 | $466.38 |
Key statistics
- Market cap
- $24.12B
- P/E (TTM)
- —
- EPS (TTM)
- −$1.05
- Revenue (TTM)
- $10.84M
- Net income (TTM)
- −$52.48M
- Shares outstanding
- 46.9M
- Dividend yield
- —
- 52-week range
- $456.66 – $538.00
InspireMD's market cap is $24.12B, based on a share price of $514.09 and 46.9M shares outstanding as of Jun 30, 2026.
Financials
InspireMD reported revenue of $8.98M for fiscal 2025, up 28.11% from fiscal 2024.
InspireMD reported a net loss of $48.79M in fiscal 2025.
Fiscal 2025 revenue was the highest in the 10 years shown.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $8.98M | +28.1% | −$48.79M | −543.3% | −$0.76 | −$36.77M |
| FY2024ended Dec 31, 2024 | $7.01M | +13.0% | −$32.01M | −456.6% | −$0.76 | −$23.27M |
| FY2023ended Dec 31, 2023 | $6.21M | +20.0% | −$19.92M | −321.0% | −$0.82 | −$16.76M |
| FY2022ended Dec 31, 2022 | $5.17M | +15.0% | −$18.49M | −357.6% | −$2.35 | −$16.02M |
| FY2021ended Dec 31, 2021 | $4.50M | +80.9% | −$14.92M | −331.9% | −$2.03 | −$13.55M |
| FY2020ended Dec 31, 2020 | $2.49M | −33.2% | −$10.54M | −424.3% | −$6.97 | −$9.17M |
| FY2019ended Dec 31, 2019 | $3.72M | +3.3% | −$10.04M | −269.8% | −$4.80 | −$10.09M |
| FY2018ended Dec 31, 2018 | $3.60M | +30.4% | −$7.24M | −201.1% | −$16.67 | −$7.67M |
| FY2017ended Dec 31, 2017 | $2.76M | +45.8% | −$8.44M | −305.6% | −$34.98 | −$8.39M |
| FY2016ended Dec 31, 2016 | $1.89M | — | −$8.46M | −446.7% | −$207.72 | — |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $1.77M | −$14.32M | −$0.17 |
| Q1 FY2026ended Mar 31, 2026 | $3.40M | −$13.69M | −$0.16 |
| Q4 FY2025ended Dec 31, 2025 | $3.15M | −$11.76M | −$0.55 |
| Q3 FY2025ended Sep 30, 2025 | $2.52M | −$12.71M | −$0.17 |
| Q2 FY2025ended Jun 30, 2025 | $1.78M | −$13.15M | −$0.26 |
| Q1 FY2025ended Mar 31, 2025 | $1.53M | −$11.17M | $0.22 |
| Q4 FY2024ended Dec 31, 2024 | $1.95M | −$9.17M | −$0.17 |
| Q3 FY2024ended Sep 30, 2024 | $1.81M | −$7.89M | −$0.16 |
Company profile
- Name
- InspireMD, Inc.
- Ticker
- NSPR
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Surgical & Medical Instruments & Apparatus
- Headquarters
- 6303 Waterford District Drive, Suite 215, Miami, FL 33126
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001433607
Recent SEC filings
- Sep 21, 2026
- Aug 17, 2026
- Aug 14, 2026
- Jul 29, 2026
- Jul 23, 2026
- Jul 2, 2026
- Jun 11, 2026
- Jun 3, 2026
Frequently asked questions
What is InspireMD's stock price?
InspireMD (NSPR) closed at $514.09 on Oct 9, 2026, up 1.09% from the previous close of $508.57.
What is InspireMD's market cap?
InspireMD's market cap is $24.12B, based on a share price of $514.09 and 46.9M shares outstanding as of Jun 30, 2026.
How much revenue does InspireMD make?
InspireMD reported revenue of $8.98M for fiscal 2025, up 28.11% from fiscal 2024.
Does InspireMD pay a dividend?
InspireMD's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from InspireMD, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures